Oxford Asset Management’s Fennec Pharmaceuticals FENC Stock Holding History

Oxford Asset Management’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$770K	Buy	129,646 +69,900	+117%	+$456K	0.11%	83
2019 Q4	$387K	Sell	59,746 -23,003	-28%	-$124K	0.01%	1349
2019 Q3	$398K	Buy	82,749 +7,513	+10%	+$33.2K	0.01%	1349
2019 Q2	$301K	Sell	75,236 -9,514	-11%	-$40.3K	0.01%	1444
2019 Q1	$411K	Buy	84,750 +70,391	+490%	+$463K	0.01%	1298
2018 Q4	$92K	Buy	+14,359	New	+$100K	﹤0.01%	1658

Other funds holding FENC

SCA

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

SFI

Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

CCM

Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Oxford Asset Management's FENC Position: Q1 2020 in Review

Oxford Asset Management increased its Fennec Pharmaceuticals (FENC) stake by 117% in Q1 2020, buying an estimated $456K and bringing the position to 129,646 shares worth $770K. The position accounts for 0.11% of the portfolio, ranked #83.

Oxford Asset Management first reported a position in FENC in Q4 2018 and has held it in 6 quarters since. 29 funds tracked by Wall St. Rank hold FENC as of Q1 2020.

Oxford Asset Management held 129,646 shares of Fennec Pharmaceuticals worth $770K as of Q1 2020.
Oxford Asset Management bought 69,900 Fennec Pharmaceuticals shares in Q1 2020, an estimated $456K.
Fennec Pharmaceuticals made up 0.11% of Oxford Asset Management's portfolio in Q1 2020, its #83 holding.
Oxford Asset Management first reported a position in Fennec Pharmaceuticals in Q4 2018 and has held it in 6 quarters since.
29 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.